Market news

Exponent demonstrates strong demand recovery, with Q2 revenue before reimbursement up 12% to $148.9M. Read why EXPO stock is a Hold.

Here is how Exponent (EXPO) and Gen Digital (GEN) have performed compared to their sector so far this year.

Moby summary of Exponent, Inc.'s Q2 2026 earnings call

Exponent (EXPO) reported fiscal Q2 earnings late Thursday of $0.60 per diluted share, up from $0.52

Exponent Inc (EXPO) delivered a strong Q2 2026 with net revenues up 12%, driven by AI integration into physical products and a large user research study, while raising its full-year guidance.

Exponent (EXPO) delivered earnings and revenue surprises of +9.09% and +3.34%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Exponent (NASDAQ:EXPO) reported double-digit revenue and earnings growth for the second quarter of 2026, supported by demand for user research involving artificial intelligence-enabled products, utility-sector risk management work, and dispute-related consulting across consumer products, chemicals a

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Corrigan sold exercised stock options.